| Identification | Back Directory | [Name]
AM2201-d5 | [CAS]
2748464-24-4 | [Synonyms]
AM2201-d5
1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl-2,4,5,6,7-d5]-1-naphthalenyl-methanone | [Molecular Formula]
C24H17D5FNO | [MOL File]
2748464-24-4.mol | [Molecular Weight]
364.467 |
| Hazard Information | Back Directory | [Description]
AM2201-d5 (exempt preparation) (Item No. 22870) is intended for use as an internal standard for the quantification of AM2201 (Item Nos. 10707 | 15668) by GC- or LC-MS. AM2201 is categorized as a synthetic cannabinoid.1 AM2201 is regulated as a Schedule I compound in the United States. AM2201-d5 (exempt preparation) (Item No. 22870) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | [Description]
AM2201-d5 (Item No. 10706) is intended for use as an internal standard for the quantification of AM2201 (Item Nos. 10707 | 15668) by GC- or LC-MS. AM2201 is categorized as a synthetic cannabinoid.1 AM2201-d5 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | [References]
[1] A K DUTTA. Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs).[J]. Bioorganic & Medicinal Chemistry, 1997, 5 8: 1591-1600. DOI: 10.1016/s0968-0896(97)00111-9 |
|
|